[Data] Neutralizing Antibodies Gaining Attention as Biopharmaceuticals eBook

Neutralizing antibodies are an example of molecules that play a decisive role in the development of vaccines and therapeutics.

In recent years, the development of monoclonal antibodies (mAb) as therapeutic agents has garnered attention. mAb is highly anticipated for the treatment of severe diseases such as cancer and other conditions that are difficult to treat. One reason for this is not only their high efficacy and low side effects but also their high specificity of response. Vaccines and effective antibody therapeutics play an essential role in suppressing the ongoing COVID-19 pandemic and newly emerging variants. Neutralizing antibodies are one example of molecules that play a decisive role in the development of vaccines and therapeutics, as they can bind to viruses and prevent infection. Neutralizing antibodies can be isolated from the plasma of recovered patients, and researchers worldwide are focusing on them to deepen the understanding of the mechanism of action (MOA) against the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. *You can download the English version of the catalog. *For more details, please refer to the PDF materials or feel free to contact us.

others